ORIGINATION, LLC – Trademark Portfolio

Entity Type: 16

ORIGINATION, LLC holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 8 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 12 trademarks are registered. Notable registered marks include O2D, MEGANION, BUFFERMAG, QUIK-MELT, and CI-MEGANION. The owner is based in MAPLEWOOD, MN.

1300 MCKNIGHT ROAD

MAPLEWOOD, MN 55119

15 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ORIGINATION, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (8 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does ORIGINATION, LLC have?

ORIGINATION, LLC has 15 U.S. trademarks filed with the USPTO. Of these, 12 registered, 3 cancelled.

What trademark classes does ORIGINATION, LLC file in?

ORIGINATION, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are ORIGINATION, LLC's most well-known trademarks?

ORIGINATION, LLC's registered trademark portfolio includes well-known marks such as O2D, MEGANION, BUFFERMAG, QUIK-MELT, and CI-MEGANION. These are among 12 currently registered trademarks in the portfolio.

What is ORIGINATION, LLC's trademark registration success rate?

ORIGINATION, LLC has a 80% trademark registration rate, with 12 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.